Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Spend Life Wisely

Ranger Small Cap Fund Institutional Class (RFISX)

Ticker RFISX · · Holdings as of Jul 31, 2026

Expense ratio
1.15%$115/yr per $10k
5-yr return
+6.6%annualized
1-yr return
+6.3%as of Dec 2024
Net assets
$12.3Mall share classes
Holdings
61

Bottom line

Is RFISX a good fund? The bottom line

RFISX is the Institutional Class share class of Ranger Small Cap Fund, an actively managed small-cap mutual fund from Spend Life Wisely.

Annual fees run 1.15% — about $115 a year on every $10,000 invested, more expensive than 66% of small-cap funds we track.

It returned +6.3% over one year, +6.6% a year over five years, +8.9% a year over ten (as of Dec 31, 2024, per its prospectus).

With $12.3 million in net assets and 61 holdings, its largest position is Ligand Pharmaceuticals, Inc. (4.5%) and the top 10 make up 30.4% of the portfolio.

What to watch

  • Small fund ($12.3 million) — small funds are likelier to close

Updated Nov 19, 2026

What RFISX invests in

The Fund seeks long-term capital appreciation.

"Under normal market conditions, the Fund invests at least 80% of its assets in common stocks of small capitalization (""small cap"") companies. The Fund defines small cap companies as those that at the time of initial purchase are within the capitalization range of the Russell 2000 Growth Index, which was $119.4 million to $7 billion as of April 30, 2025, its most recent reconstitution date. RIM's strategy begins with the narrowing of the small cap stock universe to identify companies that RIM believes have a proven track record of competitive advantages and the ability to produce sustainable value for shareholders in the foreseeable future. From this group, RIM selects securities that it believes are trading at prices below their intrinsic value. RIM sells a stock if RIM believes it is overvalued, more attractive candidates arise, or if there is a substantial, long term reduction in…

From the fund's prospectus (filed Dec 1, 2025).

RFISX performance

Average annual total returns
1 yr5 yr10 yr
RFISX+6.3%+6.6%+8.9%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2024

Full RFISX performance history →

What RFISX costs

On a $10,000 investment, RFISX's 1.15% expense ratio costs about $115 a year. The prospectus estimates $1,832 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full RFISX fee table →

RFISX top 10 holdings

#Holding% of fund
1Ligand Pharmaceuticals, Inc.4.53%
2Sharkninja, Inc.3.39%
3UL Solutions, Inc.3.34%
4Oceaneering International, Inc.3.17%
5Chime Financial, Inc.2.87%
6HealthEquity, Inc.2.80%
7PDF Solutions, Inc.2.68%
8Fidelity Institutional Cash Portfolios2.56%
9Triumph Financial, Inc.2.51%
10Casella Waste Systems, Inc.2.50%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 30.4% of the fund. See all top 25 holdings and asset mix →

Alternatives to RFISX

More funds like RFISX →

RFISX FAQ

What is the expense ratio of RFISX?
RFISX's expense ratio is 1.15%, which works out to about $115 a year for every $10,000 invested. The prospectus estimates total costs of $1,832 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is RFISX a good investment?
It depends on your goals, but the data points to: small fund ($12.3 million) — small funds are likelier to close. This is general information, not personalized advice.
What does RFISX hold?
RFISX's largest holdings are Ligand Pharmaceuticals, Inc. (4.5%), Sharkninja, Inc. (3.4%), UL Solutions, Inc. (3.3%), Oceaneering International, Inc. (3.2%), Chime Financial, Inc. (2.9%). It holds 61 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is RFISX's 5-year return?
RFISX returned +6.6% a year over the five years ending Dec 31, 2024, and +8.9% a year over ten years. Past performance does not guarantee future results.
Who manages RFISX?
RFISX is offered by Spend Life Wisely through Spend Life Wisely Funds Investment Trust.